Actos

Type: Product
Name: Actos
First reported 4 hours ago - Updated 4 hours ago - 1 reports

TAKEDA PHARMACEUTICAL : Actos Bladder Cancer Allegations Attorney Help: Resource4thePeople Informing Consumers about $9 Billion-Dollar Jury Verdict Awarded to Victim

http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.htmlResource4thePeople today announced that it is providing consumers who may have been affected by Actos bladder cancer allegations that a Louisiana jury* has awarded a man ... [Published 4 Traders - 4 hours ago]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

NY Family Wins $9 Billion in Trial Over Cancer Linked to Diabetes Drug Actos

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A Louisiana jury has awarded $9 billion to a New York man and his wife following a trial over the man's claims that his bladder cancer was caused by the popular prescription diabetes ... [Published NewsRX - Apr 19 2014]
Entities: Actos, Diabetes, Drugs, Cancer
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Big pharma struggles to balance transparency and profits

Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts lavish parties for hundreds of people each Christmas with entertainment provided in recent years by Miley Cyrus, Bon Jovi and ... [Published Irish Times - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Scripps scientists win $2M research grant

Scripps Research Institute scientists in Jupiter won a $2.1 million grant to search for an anti-diabetes drug.The National Institutes of Health provided the five-year grant to a team led by Douglas Kojetin, an associate professor. They aim to create a ... [Published Business First of Buffalo - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 17 2014 - 1 reports

Scientists awarded $2 million to study improvements in anti-diabetic drug design

PUBLIC RELEASE DATE: 16-Apr-2014JUPITER, FL, April 16, 2014 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer ... [Published EurekAlert! - Apr 16 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Cancer Monthly Advises Actos Users to Know the Symptoms of Bladder...

In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights ... [Published PRWeb - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

ELI LILLY : Takeda Responds to Verdict in Diabetes Drug Case

By a News Reporter-Staff News Editor at Diabetes Week -- Takeda Pharmaceuticals U.S.A. , Inc. announced that in the case of Terrence Allen , et al. v. Takeda Pharmaceuticals North America, Inc. , et al, No. 6:12-cv-00064 the jury found in favor of the ... [Published 4 Traders - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 16 2014 - 5 reports

Plaintiff in drug trial tells jury her story

LAS VEGAS -- For the first time, in front of a jury, one of the local women suing a major drug company told her story of how she was diagnosed with cancer after taking a medication meant to treat diabetes.That drug is called Actos.Delores Cipriano, 81 ... [Published KLAS-TV - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Takeda Loses First Federal Trial Over Actos Diabetes Drug

Takeda Pharmaceutical Co. (4502) lost thefirst federal court trial in the U.S. over claims it hid thecancer risks of its Actos diabetes medicine to protect billionsof dollars in sales.The jury in Lafayette, Louisiana, today awarded $1.5million in compensatory ... [Published Bayou Buzz - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Eli Lilly's $3 Billion Mistake

By | More ArticlesAfter a long court battle for Eli Lilly (NYSE: LLYIn this segment of Tueday's Market Checkup, Motley Fool health care analysts take a look at what appear to be massive fines at first blush, and discuss why they don't see this as a reason ... [Published Motley Fool - Apr 14 2014]
First reported Apr 13 2014 - Updated Apr 13 2014 - 1 reports

Verdict Gives Bladder Cancer Actos Users Reason for Action, According to Cancer Monthly

Days after a federal jury announced a $9 billion dollar judgment against the drug’s manufacturers, Cancer Monthly is encouraging bladder cancer patients to know their rights. The Japanese manufacturer of the diabetes drug Actos and its partner firm, Eli ... [Published PRWeb - Apr 13 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 114 reports

Actos Makers to Pay $9 Billion: Flood Law Group Investigates Lawsuits

Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages for allegedly withholding information about the potential risks associated with the diabetes drug Actos. Flood Law Group says it ... [Published PRWeb - Apr 08 2014]

Quotes

"This huge award came in the first trial in which plaintiffs for victims who are alleging that their use of Actos to treat diabetes caused them to develop bladder cancer and that the defendants did not properly warn them of this danger" said Resource4thePeople
...possible post-trial motions and an appeal," said Kenneth D Greisman , senior vice president, general counsel, Takeda Pharmaceuticals U S A Inc. "We have empathy for the Allens, but we believe the evidence did not support a finding that ACTOS caused his bladder cancer. We also believe we demonstrated that Takeda acted responsibly with regard to ACTOS."
"This unexpected finding opens a lot of potential opportunities," Kojetin said. "We're looking to design a molecule that blocks both sites and can be used to probe what this alternative binding does on a molecular level—with the hope that this information will help us come up with a better drug model." The number of the new National Institutes of Health grant is 1R01DK1
"It was a shock, really was. I couldn't figure out why he would say that" Cipriano said

More Content

All (394) | News (368) | Reports (0) | Blogs (23) | Audio/Video (0) | Fact Sheets (1) | Press Releases (2)
sort by: Date | Relevance
TAKEDA PHARMACEUTICAL : Actos Bladder Cancer Al... [Published 4 Traders - 4 hours ago]
NY Family Wins $9 Billion in Trial Over Cancer ... [Published NewsRX - Apr 19 2014]
FDA Approves Weekly Type 2 Diabetes Medicine [Published Diabetes Self-Management - Apr 19 2014]
Mark Lanier to Share Legal Perspectives at 2 Up... [Published PRWeb - Apr 18 2014]
Big pharma struggles to balance transparency an... [Published Irish Times - Apr 18 2014]
Scripps scientists win $2M research grant [Published Business First of Buffalo - Apr 17 2014]
Cancer Monthly Advises Actos Users to Know the ... [Published PRWeb - Apr 17 2014]
ELI LILLY : Takeda Responds to Verdict in Diabe... [Published 4 Traders - Apr 16 2014]
Scientists awarded $2 million to study improvem... [Published EurekAlert! - Apr 16 2014]
Tamiflu scandal exposes bloodsucking big pharma [Published Socialist Party - Apr 16 2014]
Plaintiff in drug trial tells jury her story [Published KLAS-TV - Apr 16 2014]
Jury in southwest Louisiana federal court award... [Published The Southeast Texas Record - Apr 16 2014]
Henderson woman testifies she was never informe... [Published Las Vegas Review Journal - Apr 16 2014]
FDA Approves New Type 2 Diabetes Drug-April 15,... [Published InteliHealth - Apr 15 2014]
My paper has just exposed big pharma... [Published Roll On Friday - Apr 15 2014]
Actos Appeal No Reason for Bladder Cancer Patie... [Published PRWeb - Apr 15 2014]
Takeda Loses First Federal Trial Over Actos Dia... [Published Bayou Buzz - Apr 15 2014]
Popular diabetes drug linked to cancer () [Published Yahoo! News Australia - Apr 15 2014]
Eli Lilly's $3 Billion Mistake [Published Motley Fool - Apr 14 2014]
GlaxoSmithKline accused of bribing doctors to p... [Published Mail Online UK - Apr 14 2014]
Skyline Urology Encourages Simple Urine Test To... [Published TheStreet.com - Apr 14 2014]
Verdict Gives Bladder Cancer Actos Users Reason... [Published PRWeb - Apr 13 2014]
Chinthaka Wijewickrama Elected FITIS Chairman [Published Sri Lanka Sunday Leader - Apr 12 2014]
Actos Lawsuits Move Forward, as Nevada Judge De... [Published Presscontacts.com - Apr 12 2014]
Actos Lawsuits Move Forward, as Nevada Judge De... [Published PRWeb - Apr 12 2014]
Week Adjourned: 4.11.14 – Dog Treats, Hilton Ho... [Published Lawyers & Settlements - Apr 12 2014]
Verdict Could Mean Help for Bladder Cancer Pati... [Published Digital Journal - Apr 12 2014]
Breaking News: Proposal to Amend Federal Rules ... [Published Drug and Device Law - Apr 11 2014]
Missing safety risk emails draw $9bn Actos fine [Published RSC - Apr 11 2014]
Takeda seen logging first operating profit gain... [Published Nikkei Asian Review - Apr 11 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Breaking News: Proposal to Amend Federal Rules ... [Published Drug and Device Law - Apr 11 2014]
The so-called “Duke Subcommittee” today finalized and voted on its version of proposed amendments to the Federal Rules of Civil Procedure.  These amendments include those we’ve blogged about before , making alterations to the scope of discovery, the ...
A $9 Billion Punitive Damages Verdict in Actos ... [Published New York Personal Injury Law Blog - Apr 09 2014]
We once again see a whopping punitive damages verdict and need to discuss: Just how much is too much? At issue is a $9  Billion punitive damage award against Japan’s Takeda Pharmaceutical and Eli Lilly. The case concerned the diabetes drug Actos, ...
The Takeda Verdict: Why the $9 Billion Award Wi... [Published WSJ.com: Law Blog - Apr 08 2014]
A federal jury late Monday stuck Takeda Pharmaceutical Co. and marketing partner Eli Lilly & Co. with a whopping $9 billion in punitive damages for allegedly hiding the cancer risks associated with the diabetes drug, Actos. ...
The Takeda Verdict: Why the $9 Billion Award Wi... [Published Law Blog - Apr 08 2014]
A federal jury late Monday stuck Takeda Pharmaceutical Co. and marketing partner Eli Lilly & Co. with a whopping $9 billion in punitive damages for allegedly hiding the cancer risks associated with the diabetes drug, Actos. ...
Pharmaceutical Companies Face $9B In Punitive D... [Published The Consumerist - Apr 08 2014]
( FastFords ) A Japanese drug maker is facing higher punitive damages for allegedly concealing the cancer risks associated with a diabetes drug than those dished out in the past by federal juries. The $6 billion in damages leveled against Takeda ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Fitch: Lilly's Ratings Intact Following $9B Act... [Published Fitch Ratings Headlines Corporate - Apr 08 2014]
Opening Statements Begin in Billion Dollar Acto... [Published Financial Services - Mar 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.